AlbertiKGMM, EckelRH, GrundySM, et al.; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute: American Heart Association; World Heart Federation: International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009; 120:1640–1645.
2.
JialalI, DevarajS, RajamaniU. Dysregulation of monocyte biology in metabolic syndrome. Expert Rev Endocrinol Metab, 2014; 9:213–221.
3.
JialalI, HuetBA, KaurH, et al.Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care, 2012; 35:900–904.
4.
KawaiT, AkiraS. The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol, 2010; 11:373–384.
5.
JialalI, HuetBA, PahwaR.Selective increase in monocyte p38 MAP kinase activity in metabolic syndrome. Diab Vasc Dis Res, 2015 [Epub ahead of print]; DOI: 10.1177/1479164115607829.
6.
DevarajS, ChenX, HuetBA, et al.Increased expression of Fc-γ receptors on monocytes in patients with nascent metabolic syndrome. J Clin Endocrinol Metab, 2013; 98:E1510–1515.
7.
ArthurJF, QiaoJ, ShenY, etal.ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways. J Thromb Haemost, 2012; 10:1133–1141.
8.
DanielsAB, WorthRG, DicksteinRJ, et al.Analysis of Fc_RIIA cytoplasmic tail requirements in signaling for serotonin secretion:evidence for an ITAM-dependent, PI3K-dependent pathway. Scand J Immunol, 2010; 71:232–239.
9.
LoirandG, GuérinP, PacaudP. Rho kinase in cardiovascular physiology and pathophysiology. Circ Res, 2006; 98:322–334.
10.
LiuPY, ChenJH, LinLJ, et al.Increased Rho Kinase activity in a Taiwanese population with Metabolic Syndrome. J Am Coll Cardiol, 2007; 49:1619–1624.
11.
SchinzariF, TesauroM, RovellaV, et al.Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome. Am J Physiol Endocrinol Metab, 2012; 303:806–811.
12.
Leguina-RuzziA, PereiraJ, Pereira-FloresK, et al.Increased RhoA/Rho kinase activity and markers of endothelial dysfunction in young adult subjects with metabolic syndrome. Metab Syndr Relat Disord, 2015 (In press).
